Journal Article
. 2018 Oct; 29(Suppl 4):iv238-iv255.
doi: 10.1093/annonc/mdy308.

Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

A Vogel 1 A Cervantes 2 I Chau 3 B Daniele 4 J M Llovet 5 T Meyer 6 J-C Nault 7 U Neumann 8 J Ricke 9 B Sangro 10 P Schirmacher 11 C Verslype 12 C J Zech 13 D Arnold 14 E Martinelli 15 ESMO Guidelines Committee  
  • PMID: 30285213
  •     211 citations

No abstract available

Experimental Evidence of the Antitumor, Antimetastatic and Antiangiogenic Activity of Ellagic Acid.
Claudia Ceci, Pedro M Lacal, +3 authors, Grazia Graziani.
Nutrients, 2018 Nov 18; 10(11). PMID: 30441769    Free PMC article.
The Upper Gastrointestinal Cancer Registry (UGICR): a clinical quality registry to monitor and improve care in upper gastrointestinal cancers.
Ashika D Maharaj, Jennifer F Holland, +29 authors, John R Zalcberg.
BMJ Open, 2019 Oct 03; 9(9). PMID: 31575580    Free PMC article.
Treatment Lines in Hepatocellular Carcinoma.
Henning Wege, Jun Li, Harald Ittrich.
Visc Med, 2019 Oct 12; 35(4). PMID: 31602390    Free PMC article.
Current status of stereotactic body radiotherapy for the treatment of hepatocellular carcinoma.
Jongmoo Park, Jae Won Park, Min Kyu Kang.
Yeungnam Univ J Med, 2019 Oct 18; 36(3). PMID: 31620633    Free PMC article.
Demystifying the manipulation of host immunity, metabolism, and extraintestinal tumors by the gut microbiome.
Ziying Zhang, Haosheng Tang, +2 authors, Yongguang Tao.
Signal Transduct Target Ther, 2019 Oct 23; 4. PMID: 31637019    Free PMC article.
Angiogenesis and immune checkpoint inhibitors as therapies for hepatocellular carcinoma: current knowledge and future research directions.
Marc Hilmi, Cindy Neuzillet, +3 authors, Benoit Rousseau.
J Immunother Cancer, 2019 Dec 01; 7(1). PMID: 31783782    Free PMC article.
Effectiveness of stereotactic ablative radiotherapy in patients with advanced hepatocellular carcinoma unsuitable for transarterial chemoembolization.
Hsin-Lun Lee, Jo-Ting Tsai, +13 authors, Jeng-Fong Chiou.
Ther Adv Med Oncol, 2019 Dec 17; 11. PMID: 31839809    Free PMC article.
Machine-learning analysis of contrast-enhanced CT radiomics predicts recurrence of hepatocellular carcinoma after resection: A multi-institutional study.
Gu-Wei Ji, Fei-Peng Zhu, +5 authors, Xue-Hao Wang.
EBioMedicine, 2019 Nov 19; 50. PMID: 31735556    Free PMC article.
ALPPS for hepatocarcinoma under cirrhosis: a feasible alternative to portal vein embolization.
Victor Lopez-Lopez, Ricardo Robles-Campos, +7 authors, Pascual Parrilla-Paricio.
Ann Transl Med, 2020 Jan 14; 7(22). PMID: 31930092    Free PMC article.
[Locoregional and local ablative treatment options for liver tumors].
J B Hinrichs, F K Wacker.
Internist (Berl), 2020 Jan 11; 61(2). PMID: 31919532
[Multimodal treatment of hepatocellular carcinoma].
M M Kirstein, T C Wirth.
Internist (Berl), 2020 Jan 11; 61(2). PMID: 31919533
Controversies in the management of hepatocellular carcinoma.
Alejandro Forner, Leonardo G Da Fonseca, +3 authors, Jordi Bruix.
JHEP Rep, 2020 Feb 11; 1(1). PMID: 32039350    Free PMC article.
Using circulating tumor DNA as a novel biomarker to screen and diagnose hepatocellular carcinoma: A systematic review and meta-analysis.
Ziying Zhang, Peng Chen, Hui Xie, Peiguo Cao.
Cancer Med, 2019 Dec 27; 9(4). PMID: 31876977    Free PMC article.
Systematic Review.
Ramucirumab: A Review in Hepatocellular Carcinoma.
Yahiya Y Syed.
Drugs, 2020 Feb 09; 80(3). PMID: 32034692
Case Report of Synchronous Prostate, Hepatocellular, and Rectal Carcinomas and Review of the Literature.
Viktoria Lamprou, Daniel Paramythiotis, +5 authors, Stefanos Finitsis.
Case Rep Surg, 2020 Feb 25; 2020. PMID: 32089942    Free PMC article.
SLMP53-2 Restores Wild-Type-Like Function to Mutant p53 through Hsp70: Promising Activity in Hepatocellular Carcinoma.
Sara Gomes, Bartolomeo Bosco, +18 authors, Lucília Saraiva.
Cancers (Basel), 2019 Aug 14; 11(8). PMID: 31405179    Free PMC article.
Hepatic Resection Is Associated With Improved Long-Term Survival Compared to Radio-Frequency Ablation in Patients With Multifocal Hepatocellular Carcinoma.
Yang-Yang Yue, Wei-Li Zhou.
Front Oncol, 2020 Mar 03; 10. PMID: 32117759    Free PMC article.
Cabozantinib: A Review in Advanced Hepatocellular Carcinoma.
Emma D Deeks.
Target Oncol, 2019 Feb 16; 14(1). PMID: 30767164
The Changing Landscape of Systemic Treatment of Advanced Hepatocellular Carcinoma: New Targeted Agents and Immunotherapies.
Jens U Marquardt, Anna Saborowski, Carolin Czauderna, Arndt Vogel.
Target Oncol, 2019 Feb 26; 14(2). PMID: 30805831
Evaluation of Polymer Nanoformulations in Hepatoma Therapy by Established Rodent Models.
Qilong Wang, Ping Zhang, +6 authors, Xuesi Chen.
Theranostics, 2019 Mar 15; 9(5). PMID: 30867842    Free PMC article.
Programmed cell death protein-1 (PD-1)-targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre real-world cohort.
Bernhard Scheiner, Martha M Kirstein, +18 authors, Matthias Pinter.
Aliment Pharmacol Ther, 2019 Apr 14; 49(10). PMID: 30980420    Free PMC article.
Preoperative Stereotactic Body Radiotherapy to Portal Vein Tumour Thrombus in Hepatocellular Carcinoma: Clinical and Pathological Analysis.
Noriko Kishi, Naoyuki Kanayama, +12 authors, Teruki Teshima.
Sci Rep, 2020 Mar 07; 10(1). PMID: 32139751    Free PMC article.
Haprolid Inhibits Tumor Growth of Hepatocellular Carcinoma through Rb/E2F and Akt/mTOR Inhibition.
Jun Xing, Vikas Bhuria, +10 authors, Ruben R Plentz.
Cancers (Basel), 2020 Mar 12; 12(3). PMID: 32155915    Free PMC article.
Recent advances in unraveling the molecular mechanisms and functions of HOXA11‑AS in human cancers and other diseases (Review).
Cheng Wei, Liangjuan Zhao, +2 authors, Lei Han.
Oncol Rep, 2020 Apr 03; 43(6). PMID: 32236611    Free PMC article.
Hepatocellular carcinoma in older adults: A comprehensive review by Young International Society of Geriatric Oncology.
Sukeshi Patel Arora, Gabor Liposits, +6 authors, Efrat Dotan.
J Geriatr Oncol, 2019 Nov 11; 11(4). PMID: 31704038    Free PMC article.
Recommendations for the use of radiation therapy in managing patients with gastrointestinal malignancies in the era of COVID-19.
Leila T Tchelebi, Karin Haustermans, +5 authors, Karyn A Goodman.
Radiother Oncol, 2020 Apr 29; 148. PMID: 32342878    Free PMC article.
A Novel Pre-treatment Model Predicting Risk of Developing Refractoriness to Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma.
Keshu Hu, Shenxin Lu, +8 authors, Xin Yin.
J Cancer, 2020 Jun 04; 11(15). PMID: 32489476    Free PMC article.
Sorafenib for the treatment of hepatocellular carcinoma: a single-centre real-world study.
Jurij Hanzel, Tajda Kosir Bozic, Borut Stabuc, Rado Jansa.
Radiol Oncol, 2020 May 29; 54(2). PMID: 32463391    Free PMC article.
Development and Validation of Pre- and Post-Operative Models to Predict Recurrence After Resection of Solitary Hepatocellular Carcinoma: A Multi-Institutional Study.
Ming-Yu Wu, Qian Qiao, +3 authors, Xiang-Cheng Li.
Cancer Manag Res, 2020 Jun 12; 12. PMID: 32523380    Free PMC article.
Hepatocellular carcinoma: recent advances and emerging medical therapies.
Kwan-Lung Ko, Lung-Yi Mak, Ka-Shing Cheung, Man-Fung Yuen.
F1000Res, 2020 Jul 01; 9. PMID: 32595940    Free PMC article.
Follow-up schedule for initial recurrent hepatocellular carcinoma after ablation based on risk classification.
Xuqi Sun, Lingling Li, +3 authors, Ming Zhao.
Cancer Imaging, 2020 Jul 03; 20(1). PMID: 32611383    Free PMC article.
Transarterial Infusion of Epirubicin and Cisplatin Combined With Systemic Infusion of 5-Flurouracil Versus Sorafenib for Hepatocellular Carcinoma With Refractoriness of Transarterial Chemoembolization Using Doxorubicin.
Sun Hong Yoo, Jung Hyun Kwon, +5 authors, Jeong Won Jang.
Cancer Control, 2020 Jun 26; 27(2). PMID: 32583687    Free PMC article.
Cured giant hepatocellular carcinoma after transarterial embolization complicated with liver abscess formation.
Malkhaz Mizandari, Tamta Azrumelashvili, +5 authors, Tinatin Chikovani.
Radiol Case Rep, 2020 Jul 17; 15(9). PMID: 32670446    Free PMC article.
Deep learning-based classification and mutation prediction from histopathological images of hepatocellular carcinoma.
Haotian Liao, Yuxi Long, +10 authors, Yong Zeng.
Clin Transl Med, 2020 Jun 15; 10(2). PMID: 32536036    Free PMC article.
Epidemiologic, humanistic and economic burden of hepatocellular carcinoma in the USA: a systematic literature review.
Abdalla Aly, Sarah Ronnebaum, +2 authors, Fernando Benavente.
Hepat Oncol, 2020 Aug 11; 7(3). PMID: 32774837    Free PMC article.
Immunotherapy in Hepatocellular Cancer Patients with Mild to Severe Liver Dysfunction: Adjunctive Role of the ALBI Grade.
David J Pinato, Takahiro Kaneko, +23 authors, Yi-Hsiang Huang.
Cancers (Basel), 2020 Jul 16; 12(7). PMID: 32664319    Free PMC article.
Management of Adverse Events Associated with Cabozantinib Treatment in Patients with Advanced Hepatocellular Carcinoma.
Gabriel Schwartz, Julianne O Darling, Malori Mindo, Lucia Damicis.
Target Oncol, 2020 Aug 10; 15(4). PMID: 32770441    Free PMC article.
Effectiveness and Safety of Nivolumab in Child-Pugh B Patients with Hepatocellular Carcinoma: A Real-World Cohort Study.
Won-Mook Choi, Danbi Lee, +8 authors, Jonggi Choi.
Cancers (Basel), 2020 Jul 24; 12(7). PMID: 32698355    Free PMC article.
Novel molecular targets in hepatocellular carcinoma.
Ariel Ka-Man Chow, Simon Wing-Lung Yau, Lui Ng.
World J Clin Oncol, 2020 Sep 04; 11(8). PMID: 32879846    Free PMC article.
Traditional Chinese medicine as supportive care for the management of liver cancer: Past, present, and future.
Xia Liao, Yang Bu, Qingan Jia.
Genes Dis, 2020 Sep 05; 7(3). PMID: 32884991    Free PMC article.
Comparative Efficacy of Cabozantinib and Regorafenib for Advanced Hepatocellular Carcinoma.
Robin K Kelley, Patrick Mollon, +7 authors, Ghassan K Abou-Alfa.
Adv Ther, 2020 May 20; 37(6). PMID: 32424805    Free PMC article.
Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study.
Petros Fessas, Ahmed Kaseb, +24 authors, David J Pinato.
J Immunother Cancer, 2020 Sep 02; 8(2). PMID: 32868393    Free PMC article.
Identification of diagnostic and prognostic biomarkers, and candidate targeted agents for hepatitis B virus-associated early stage hepatocellular carcinoma based on RNA-sequencing data.
Zhili Zeng, Zebiao Cao, Ying Tang.
Oncol Lett, 2020 Sep 25; 20(5). PMID: 32968453    Free PMC article.
Weighing the benefits of hepatocellular carcinoma surveillance against potential harms.
Daniel Geh, Fahd A Rana, Helen L Reeves.
J Hepatocell Carcinoma, 2019 Jan 23; 6. PMID: 30666302    Free PMC article.
Multi-modal image analysis for semi-automatic segmentation of the total liver and liver arterial perfusion territories for radioembolization.
Esmaeel Jafargholi Rangraz, Walter Coudyzer, +3 authors, Johan Nuyts.
EJNMMI Res, 2019 Feb 23; 9(1). PMID: 30788640    Free PMC article.
Downregulation of nucleolar and spindle-associated protein 1 expression suppresses liver cancer cell function.
Yifan Wang, Linling Ju, +5 authors, Zhaolian Bian.
Exp Ther Med, 2019 Apr 03; 17(4). PMID: 30936967    Free PMC article.
Theranostics in Interventional Oncology: Versatile Carriers for Diagnosis and Targeted Image-Guided Minimally Invasive Procedures.
Nils Degrauwe, Arnaud Hocquelet, +3 authors, Rafael Duran.
Front Pharmacol, 2019 May 31; 10. PMID: 31143114    Free PMC article.
Biomarkers vs imaging in the early detection of hepatocellular carcinoma and prognosis.
Lavinia Alice Balaceanu.
World J Clin Cases, 2019 Aug 01; 7(12). PMID: 31363465    Free PMC article.
Stereotactic Body Radiotherapy as a Salvage Therapy after Incomplete Radiofrequency Ablation for Hepatocellular Carcinoma: A Retrospective Propensity Score Matching Study.
Yang-Xun Pan, Mian Xi, +10 authors, Yao-Jun Zhang.
Cancers (Basel), 2019 Aug 08; 11(8). PMID: 31387248    Free PMC article.
Surveillance and diagnosis of hepatocellular carcinoma: A systematic review.
Sonia Pascual, Cayetano Miralles, +2 authors, Mariana Planells.
World J Clin Cases, 2019 Sep 19; 7(16). PMID: 31531321    Free PMC article.
Sorafenib for Patients with Hepatocellular Carcinoma and Child-Pugh B Liver Cirrhosis: Lessons Learned from a Terminated Study.
Tim A Labeur, Roos Achterbergh, +3 authors, Heinz-Josef Klümpen.
Oncologist, 2019 Oct 28; 25(9). PMID: 31645371    Free PMC article.
Prognosis of Early-Stage Hepatocellular Carcinoma: Comparison between Trans-Arterial Chemoembolization and Radiofrequency Ablation.
Byung-Yoon Yun, Hye Won Lee, +5 authors, Beom Kyung Kim.
Cancers (Basel), 2020 Sep 10; 12(9). PMID: 32899584    Free PMC article.
Update on the Genetics of and Systemic Therapy Options for Combined Hepatocellular Cholangiocarcinoma.
Alexander A Azizi, Andreas V Hadjinicolaou, +2 authors, Bristi Basu.
Front Oncol, 2020 Oct 27; 10. PMID: 33102226    Free PMC article.
Gadoxetic acid-based hepatobiliary MRI in hepatocellular carcinoma.
Jens Ricke, Ingo G Steffen, +12 authors, Max Seidensticker.
JHEP Rep, 2020 Oct 27; 2(6). PMID: 33103093    Free PMC article.
Combinational Immunotherapy for Hepatocellular Carcinoma: Radiotherapy, Immune Checkpoint Blockade and Beyond.
Yun Hua Lee, David Tai, +2 authors, Valerie Chew.
Front Immunol, 2020 Oct 30; 11. PMID: 33117354    Free PMC article.
Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Status and Novel Perspectives.
Piera Federico, Angelica Petrillo, +8 authors, Bruno Daniele.
Cancers (Basel), 2020 Oct 22; 12(10). PMID: 33080958    Free PMC article.
Stereotactic Body Radiotherapy vs. Radiofrequency Ablation in the Treatment of Hepatocellular Carcinoma: A Meta-Analysis.
Yang-Xun Pan, Yi-Zhen Fu, +8 authors, Yao-Jun Zhang.
Front Oncol, 2020 Nov 17; 10. PMID: 33194569    Free PMC article.
Systematic Review.
Percutaneous Radiofrequency Ablation Combined With Transarterial Chemoembolization Plus Sorafenib for Large Hepatocellular Carcinoma Invading the Portal Venous System: A Prospective Randomized Study.
Xiaoyan Ding, Wei Sun, +10 authors, Bozhi Liu.
Front Oncol, 2020 Nov 17; 10. PMID: 33194699    Free PMC article.
Management of patients with intermediate stage hepatocellular carcinoma.
David Prince, Ken Liu, +4 authors, Jiansong Ji.
Ther Adv Med Oncol, 2020 Nov 24; 12. PMID: 33224278    Free PMC article.
Selective internal radiation therapies for unresectable early-, intermediate- or advanced-stage hepatocellular carcinoma: systematic review, network meta-analysis and economic evaluation.
Matthew Walton, Ros Wade, +6 authors, Alison Eastwood.
Health Technol Assess, 2020 Oct 02; 24(48). PMID: 33001024    Free PMC article.
Systematic Review.
Reason of Discontinuation After Transarterial Chemoembolization Influences Survival in Patients with Hepatocellular Carcinoma.
Tim A Labeur, R Bart Takkenberg, Heinz-Josef Klümpen, Otto M van Delden.
Cardiovasc Intervent Radiol, 2018 Nov 30; 42(2). PMID: 30488302    Free PMC article.
YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role.
Matthias Van Haele, Iván M Moya, +9 authors, Tania Roskams.
Int J Mol Sci, 2019 Feb 06; 20(3). PMID: 30717258    Free PMC article.
Lenvatinib: A Review in Hepatocellular Carcinoma.
Zaina T Al-Salama, Yahiya Y Syed, Lesley J Scott.
Drugs, 2019 Apr 18; 79(6). PMID: 30993651
Combination of radiofrequency ablation and transcatheter arterial chemoembolization to treat hepatocellular carcinoma: measurement of distance from needle tip to nodule for assessment of local tumor progression.
Wang Haochen, Wang Jian, +3 authors, Zou Yinghua.
J Int Med Res, 2019 Apr 26; 47(6). PMID: 31020891    Free PMC article.
Human Liver Regeneration: An Etiology Dependent Process.
Matthias Van Haele, Janne Snoeck, Tania Roskams.
Int J Mol Sci, 2019 May 15; 20(9). PMID: 31083462    Free PMC article.
The CIREL Cohort: A Prospective Controlled Registry Studying the Real-Life Use of Irinotecan-Loaded Chemoembolisation in Colorectal Cancer Liver Metastases: Interim Analysis.
Philippe L Pereira, Roberto Iezzi, +20 authors, Julien Taieb.
Cardiovasc Intervent Radiol, 2020 Sep 26; 44(1). PMID: 32974773    Free PMC article.
Time to stop using hepatic arterial infusion chemotherapy (HAIC) for advanced hepatocellular carcinoma?-the SCOOP-2 trial experience.
Markus Peck-Radosavljevic, Simona Bota, Florian Hucke.
Ann Transl Med, 2020 Dec 15; 8(21). PMID: 33313085    Free PMC article.
Short-term Safety and Quality of Life Outcomes Following Radioembolization in Primary and Secondary Liver Tumours: a Multi-centre Analysis of 200 Patients in France.
Romaric Loffroy, Maxime Ronot, +17 authors, CIRT-FR Principal Investigators.
Cardiovasc Intervent Radiol, 2020 Sep 26; 44(1). PMID: 32975600    Free PMC article.
Current locoregional therapies and treatment strategies in hepatocellular carcinoma.
L Cardarelli-Leite, A Hadjivassiliou, +6 authors, D M Liu.
Curr Oncol, 2020 Dec 22; 27(Suppl 3). PMID: 33343208    Free PMC article.
Role of immunotherapy in the management of hepatocellular carcinoma: current standards and future directions.
A Weinmann, P R Galle.
Curr Oncol, 2020 Dec 22; 27(Suppl 3). PMID: 33343209    Free PMC article.
Potential Role of Adjuvant Lenvatinib in Improving Disease-Free Survival for Patients With High-Risk Hepatitis B Virus-Related Hepatocellular Carcinoma Following Liver Transplantation: A Retrospective, Case Control Study.
Bing Han, Han Ding, +4 authors, Jinyang Gu.
Front Oncol, 2020 Dec 29; 10. PMID: 33365268    Free PMC article.
Selecting the first line treatment in non-metastatic hepatocellular carcinoma - comparing clinical practice guidelines.
Soumya Jogi, Radha Varanai, Sravani S Bantu, Ashish Manne.
Oncol Rev, 2021 Jan 12; 14(2). PMID: 33425223    Free PMC article.
Regional liver function analysis with gadoxetic acid-enhanced MRI and virtual hepatectomy: prediction of postoperative short-term outcomes for HCC.
Mengqi Huang, Shunli Shen, +5 authors, Shi-Ting Feng.
Eur Radiol, 2021 Jan 16; 31(7). PMID: 33449173
Adoptive Cell Therapy in Hepatocellular Carcinoma: Biological Rationale and First Results in Early Phase Clinical Trials.
Philippe Rochigneux, Brice Chanez, +3 authors, Marine Gilabert.
Cancers (Basel), 2021 Jan 17; 13(2). PMID: 33450845    Free PMC article.
S100P as a novel biomarker of microvascular invasion and portal vein tumor thrombus in hepatocellular carcinoma.
Lu-Nan Qi, Liang Ma, +11 authors, Le-Qun Li.
Hepatol Int, 2021 Jan 27; 15(1). PMID: 33495903
Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma.
Josep M Llovet, Thierry De Baere, +4 authors, Riccardo Lencioni.
Nat Rev Gastroenterol Hepatol, 2021 Jan 30; 18(5). PMID: 33510460
Therapeutic Decision Making in Hepatocellular Carcinoma According to Age and Child-Pugh Class: A Nationwide Cohort Analysis in South Korea.
Sunmin Park, Chai Hong Rim, Young Kul Jung, Won Sup Yoon.
Can J Gastroenterol Hepatol, 2021 Jan 29; 2021. PMID: 33505941    Free PMC article.
Optimizing Survival and the Changing Landscape of Targeted Therapy for Intermediate and Advanced Hepatocellular Carcinoma: A Systematic Review.
Howard Lim, Ravi Ramjeesingh, +4 authors, Brandon M Meyers.
J Natl Cancer Inst, 2020 Sep 09; 113(2). PMID: 32898239    Free PMC article.
Systematic Review.
Impact of anesthesia methods on perioperative systemic inflammation and long-term outcomes in patients undergoing surgery for hepatocellular carcinoma: a propensity score-matched analysis.
Hao Zhang, Kefang Guo, +8 authors, Changhong Miao.
Ann Transl Med, 2021 Feb 09; 9(1). PMID: 33553342    Free PMC article.
Hepatocellular carcinoma in non-alcoholic fatty liver disease-a review of an emerging challenge facing clinicians.
Daniel Geh, Derek M Manas, Helen L Reeves.
Hepatobiliary Surg Nutr, 2021 Feb 13; 10(1). PMID: 33575290    Free PMC article.
Prognostic evaluation of HCC patients undergoing surgical resection: an analysis of 8 different staging systems.
Jan Bednarsch, Zoltan Czigany, +7 authors, Sven Arke Lang.
Langenbecks Arch Surg, 2020 Dec 10; 406(1). PMID: 33294952    Free PMC article.
Integrated bioinformatic analysis of RNA binding proteins in hepatocellular carcinoma.
Ling Wang, Zhen Zhang, +2 authors, Baocai Xing.
Aging (Albany NY), 2021 Jan 08; 13(2). PMID: 33411682    Free PMC article.
Patterns, timing, and predictors of recurrence after laparoscopic liver resection for hepatocellular carcinoma: results from a high-volume HPB center.
Haili Zhang, Fei Liu, +2 authors, Yonggang Wei.
Surg Endosc, 2021 Feb 24; 36(2). PMID: 33620568    Free PMC article.
Pattern of progression in advanced hepatocellular carcinoma treated with ramucirumab.
Maria Reig, Peter R Galle, +9 authors, Andrew X Zhu.
Liver Int, 2020 Nov 15; 41(3). PMID: 33188713    Free PMC article.
Distinct and Overlapping Roles of Hippo Effectors YAP and TAZ During Human and Mouse Hepatocarcinogenesis.
Haichuan Wang, Jingxiao Wang, +14 authors, Xin Chen.
Cell Mol Gastroenterol Hepatol, 2020 Nov 25; 11(4). PMID: 33232824    Free PMC article.
Morphophenotypic Classification of Hepatocellular Carcinoma: the Biliary/Stem Cell Subgroup and Worst Outcome-Implications on Patient Selection.
Rui Caetano Oliveira, Ricardo Martins, +8 authors, Maria Augusta Cipriano.
J Gastrointest Surg, 2020 May 16; 25(3). PMID: 32410177
AI-Based Radiological Imaging for HCC: Current Status and Future of Ultrasound.
Hitoshi Maruyama, Tadashi Yamaguchi, Hiroaki Nagamatsu, Shuichiro Shiina.
Diagnostics (Basel), 2021 Mar 07; 11(2). PMID: 33673229    Free PMC article.
Impact of contouring methods on pre-treatment and post-treatment dosimetry for the prediction of tumor control and survival in HCC patients treated with selective internal radiation therapy.
Guillaume Nodari, Romain Popoff, +13 authors, Alexandre Cochet.
EJNMMI Res, 2021 Mar 10; 11(1). PMID: 33687596    Free PMC article.
The Cost-Effectiveness of Lenvatinib in the Treatment of Advanced or Unresectable Hepatocellular Carcinoma from a Canadian Perspective.
Brandon M Meyers, Arndt Vogel, +6 authors, Suthakar Sabapathy.
Can J Gastroenterol Hepatol, 2021 Mar 09; 2021. PMID: 33681090    Free PMC article.
Effect of Yttrium-90 transarterial radioembolization in patients with non-surgical hepatocellular carcinoma: A systematic review and meta-analysis.
Simon Lemieux, Alex Buies, +4 authors, Steeve Provencher.
PLoS One, 2021 Mar 05; 16(3). PMID: 33662011    Free PMC article.
Systematic Review.
Albumin-bilirubin index and platelet-albumin-bilirubin index contribute to identifying survival benefit candidates in patients with hepatocellular carcinoma and Child-Pugh grade A undergoing transcatheter arterial chemoembolization with sorafenib treatment.
Keshu Hu, Jia Yuan, +6 authors, Xin Yin.
Ann Transl Med, 2021 Mar 13; 9(3). PMID: 33708864    Free PMC article.
Ultrasound or Sectional Imaging Techniques as Screening Tools for Hepatocellular Carcinoma: Fall Forward or Move Forward?
Zeno Sparchez, Rares Craciun, +6 authors, Tudor Mocan.
J Clin Med, 2021 Mar 07; 10(5). PMID: 33668839    Free PMC article.
3-Methyladenine-enhanced susceptibility to sorafenib in hepatocellular carcinoma cells by inhibiting autophagy.
Fangfang Zhao, Guohe Feng, +5 authors, Yongzhen Zhai.
Anticancer Drugs, 2021 Jan 05; 32(4). PMID: 33395067    Free PMC article.
Identifying SLC27A5 as a potential prognostic marker of hepatocellular carcinoma by weighted gene co-expression network analysis and in vitro assays.
Fan Zhang, Mengjuan Xue, +5 authors, Zhijun Bao.
Cancer Cell Int, 2021 Mar 19; 21(1). PMID: 33731144    Free PMC article.
Organ specific responses to first-line lenvatinib plus anti-PD-1 antibodies in patients with unresectable hepatocellular carcinoma: a retrospective analysis.
Cheng Huang, Xiao-Dong Zhu, +8 authors, Hui-Chuan Sun.
Biomark Res, 2021 Mar 22; 9(1). PMID: 33743822    Free PMC article.
Performance of initial LI-RADS 2018 treatment response in predicting survival of patients with hepatocellular carcinoma following TACE: a retrospective, single-center cohort study.
Krzysztof Bartnik, Joanna Podgórska, +7 authors, Olgierd Rowiński.
J Cancer Res Clin Oncol, 2021 Mar 30; 147(12). PMID: 33778924    Free PMC article.
Polo-Like Kinase 4's Critical Role in Cancer Development and Strategies for Plk4-Targeted Therapy.
Xiaoyang Zhang, Cheng Wei, Hao Liang, Lei Han.
Front Oncol, 2021 Mar 30; 11. PMID: 33777739    Free PMC article.
Hepatocellular Carcinoma Immune Landscape and the Potential of Immunotherapies.
Julie Giraud, Domitille Chalopin, Jean-Frédéric Blanc, Maya Saleh.
Front Immunol, 2021 Apr 06; 12. PMID: 33815418    Free PMC article.
Comparative Efficacy of Cabozantinib and Ramucirumab After Sorafenib for Patients with Hepatocellular Carcinoma and Alpha-fetoprotein ≥ 400 ng/mL: A Matching-Adjusted Indirect Comparison.
Jörg Trojan, Patrick Mollon, +9 authors, Marino Venerito.
Adv Ther, 2021 Apr 07; 38(5). PMID: 33822328    Free PMC article.
How to Treat Hepatocellular Carcinoma in Elderly Patients.
Piera Federico, Emilio Francesco Giunta, +6 authors, Bruno Daniele.
Pharmaceuticals (Basel), 2021 Apr 04; 14(3). PMID: 33800217    Free PMC article.
Review of Intra-Arterial Therapies for Colorectal Cancer Liver Metastasis.
Justin Kwan, Uei Pua.
Cancers (Basel), 2021 Apr 04; 13(6). PMID: 33803606    Free PMC article.
Immunmodulatory Treatment Strategies of Hepatocellular Carcinoma: From Checkpoint Inhibitors Now to an Integrated Approach in the Future.
Matthias Ocker, Christian Mayr, +2 authors, Daniel Neureiter.
Cancers (Basel), 2021 Apr 04; 13(7). PMID: 33805268    Free PMC article.
Advances in immunotherapy for hepatocellular carcinoma.
Bruno Sangro, Pablo Sarobe, Sandra Hervás-Stubbs, Ignacio Melero.
Nat Rev Gastroenterol Hepatol, 2021 Apr 15; 18(8). PMID: 33850328    Free PMC article.
Optimal stereotactic body radiotherapy dosage for hepatocellular carcinoma: a multicenter study.
Ting-Shi Su, Qiu-Hua Liu, +7 authors, Le-Qun Li.
Radiat Oncol, 2021 Apr 23; 16(1). PMID: 33882972    Free PMC article.
Safety and Efficacy of Degradable Starch Microspheres Transcatheter Arterial Chemoembolization as a Bridging Therapy in Patients with Early Stage Hepatocellular Carcinoma and Child-Pugh Stage B Eligible for Liver Transplant.
Roberto Minici, Michele Ammendola, +6 authors, Domenico Laganà.
Front Pharmacol, 2021 Apr 27; 12. PMID: 33897421    Free PMC article.
Safety and Efficacy of Degradable Starch Microspheres Transcatheter Arterial Chemoembolization (DSM-TACE) in the Downstaging of Intermediate-Stage Hepatocellular Carcinoma (HCC) in Patients With a Child-Pugh Score of 8-9.
Roberto Minici, Michele Ammendola, +5 authors, Domenico Laganà.
Front Pharmacol, 2021 Apr 27; 12. PMID: 33897422    Free PMC article.
Imaging features and outcomes in patients with ruptured hepatocellular carcinoma following transcatheter arterial chemoembolization: a retrospective clinical study.
Wenpeng Zhao, Xiaopu Hou, +7 authors, Changqing Li.
J Int Med Res, 2021 Apr 16; 49(4). PMID: 33853433    Free PMC article.
Comparison of liver exposure in CT-guided high-dose rate (HDR) interstitial brachytherapy versus SBRT in hepatocellular carcinoma.
Franziska Walter, Lukas Nierer, +10 authors, Stefanie Corradini.
Radiat Oncol, 2021 May 08; 16(1). PMID: 33957941    Free PMC article.
Locoregional therapy in hepatocellular carcinoma: when to start and when to stop and when to revisit.
J J X Lee, D W-M Tai, S P Choo.
ESMO Open, 2021 Apr 23; 6(3). PMID: 33887687    Free PMC article.
Sequential Systemic Treatment in Advanced Hepatocellular Carcinoma Is Able to Prolong Median Survival to More than 3 Years in a Selected Real-World Cohort.
Johann von Felden, Kathrin Karkmann, +6 authors, Kornelius Schulze.
Visc Med, 2021 May 14; 37(2). PMID: 33981749    Free PMC article.
Response prediction of hepatocellular carcinoma undergoing transcatheter arterial chemoembolization: unlocking the potential of CT texture analysis through nested decision tree models.
Jan Vosshenrich, Christoph J Zech, +5 authors, Daniel T Boll.
Eur Radiol, 2020 Dec 05; 31(6). PMID: 33274405    Free PMC article.
Mechanistic Modelling Identifies and Addresses the Risks of Empiric Concentration-Guided Sorafenib Dosing.
Warit Ruanglertboon, Michael J Sorich, Ashley M Hopkins, Andrew Rowland.
Pharmaceuticals (Basel), 2021 May 01; 14(5). PMID: 33919091    Free PMC article.
Selection of first-line systemic therapies for advanced hepatocellular carcinoma: A network meta-analysis of randomized controlled trials.
Yue Han, Wei-Hua Zhi, +3 authors, Jian-Feng Luo.
World J Gastroenterol, 2021 May 28; 27(19). PMID: 34040331    Free PMC article.
Biomarkers for hepatocellular carcinoma based on body fluids and feces.
Ming-Cheng Guan, Wei Ouyang, +9 authors, Tian Yang.
World J Gastrointest Oncol, 2021 May 28; 13(5). PMID: 34040698    Free PMC article.
The Prognostic Correlation of Heart Rate Variability at Diagnosis with Survival of Patients with Hepatocellular Carcinoma.
Ana-Maria Ciurea, Dan Ionuț Gheonea, +3 authors, Cristin Constantin Vere.
Diagnostics (Basel), 2021 Jun 03; 11(5). PMID: 34067711    Free PMC article.
Alpha-fetoprotein response at different time-points is associated with efficacy of nivolumab monotherapy for unresectable hepatocellular carcinoma.
Wei Teng, Chen-Chun Lin, +4 authors, Shi-Ming Lin.
Am J Cancer Res, 2021 Jun 08; 11(5). PMID: 34094688    Free PMC article.
Biomarkers in Hepatobiliary Cancers: What is Useful in Clinical Practice?
Alice Boilève, Marc Hilmi, +2 authors, Cindy Neuzillet.
Cancers (Basel), 2021 Jun 03; 13(11). PMID: 34070929    Free PMC article.
Peritumoral Dilation Radiomics of Gadoxetate Disodium-Enhanced MRI Excellently Predicts Early Recurrence of Hepatocellular Carcinoma without Macrovascular Invasion After Hepatectomy.
Huanhuan Chong, Yuda Gong, +4 authors, Mengsu Zeng.
J Hepatocell Carcinoma, 2021 Jun 18; 8. PMID: 34136422    Free PMC article.
Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma.
Lili Li, Rongrong Xie, Guangrong Lu.
Biosci Rep, 2021 May 25; 41(6). PMID: 34027555    Free PMC article.
Cancer and hepatic steatosis.
R Paternostro, W Sieghart, M Trauner, M Pinter.
ESMO Open, 2021 Jun 18; 6(4). PMID: 34139486    Free PMC article.
Value of spectral detector computed tomography for the early assessment of technique efficacy after microwave ablation of hepatocellular carcinoma.
Robert Peter Reimer, Nils Große Hokamp, +8 authors, Christian Wybranski.
PLoS One, 2021 Jun 16; 16(6). PMID: 34129650    Free PMC article.
Multi-scale and multi-parametric radiomics of gadoxetate disodium-enhanced MRI predicts microvascular invasion and outcome in patients with solitary hepatocellular carcinoma ≤ 5 cm.
Huan-Huan Chong, Li Yang, +5 authors, Meng-Su Zeng.
Eur Radiol, 2021 Jan 16; 31(7). PMID: 33447861    Free PMC article.
Evaluation of Hepatocellular Carcinoma Patients: Interim Analysis of Cases from a Tertiary Referral Center in Craiova, Romania.
Ana-Maria Ciurea, Cristin Constantin Vere, +5 authors, Dan-Ionuţ Gheonea.
Curr Health Sci J, 2021 Jul 03; 47(1). PMID: 34211741    Free PMC article.
Feasibility of SBRT for hepatocellular carcinoma in Brazil - a prospective pilot study.
Andre Tsin Chih Chen, Fabio Payão, +7 authors, Flair José Carrilho.
Rep Pract Oncol Radiother, 2021 Jul 03; 26(2). PMID: 34211773    Free PMC article.
Choledocho-nodal Fistula: Uncommon Cause of Obstructive Jaundice in a Patient with HCC Diagnosed by Combined ERCP/EUS.
Mohamed H Emara, Mariam S Zaghloul, Aya M Mahros, Emad H Ema.
J Clin Imaging Sci, 2021 Jul 06; 11. PMID: 34221641    Free PMC article.
The ratio of preoperative alpha-fetoprotein level to total tumor volume as a prognostic factor of hepatocellular carcinoma after liver transplantation.
Tao Jiang, Xiao-Shi Zhang, +5 authors, Ren Lang.
Medicine (Baltimore), 2021 Jul 01; 100(26). PMID: 34190174    Free PMC article.
Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: A Subgroup Analysis of Asian Patients in the Phase 3 KEYNOTE-240 Trial.
Masatoshi Kudo, Ho Yeong Lim, +11 authors, Baek-Yeol Ryoo.
Liver Cancer, 2021 Jul 10; 10(3). PMID: 34239813    Free PMC article.
The Pattern of Progression Defines Post-progression Survival in Patients with Hepatocellular Carcinoma Treated with SIRT.
Manuel de la Torre-Aláez, Carlota Jordán-Iborra, +7 authors, Bruno Sangro.
Cardiovasc Intervent Radiol, 2020 Mar 14; 43(8). PMID: 32166352
An excellent nomogram predicts microvascular invasion that cannot independently stratify outcomes of small hepatocellular carcinoma.
Huanhuan Chong, Peiyun Zhou, Chun Yang, Mengsu Zeng.
Ann Transl Med, 2021 Jul 17; 9(9). PMID: 34268370    Free PMC article.
An evaluation of the reporting quality in clinical practice guidelines for hepatocellular carcinoma using the RIGHT checklist.
Haiyang Chen, Meng Tao, +9 authors, Qiming Wang.
Ann Transl Med, 2021 Jul 20; 9(12). PMID: 34277804    Free PMC article.
Application of ultrasound combined with enhanced MRI by Gd-BOPTA in diagnosing hepatocellular carcinoma.
Shuwen Ji, Ziyong Wang, Shiyong Xia.
Am J Transl Res, 2021 Jul 27; 13(6). PMID: 34306478    Free PMC article.
Hepatocellular carcinoma: a clinical and pathological overview.
Salvatore Lorenzo Renne, Samantha Sarcognato, +4 authors, Luca Di Tommaso.
Pathologica, 2021 Jul 24; 113(3). PMID: 34294938    Free PMC article.
The immunological and metabolic landscape in primary and metastatic liver cancer.
Xin Li, Pierluigi Ramadori, +3 authors, Mathias Heikenwalder.
Nat Rev Cancer, 2021 Jul 31; 21(9). PMID: 34326518
Role of ssDNA as a Noninvasive Indicator for the Diagnosis and Prognosis of Hepatocellular Carcinoma: An Exploratory Study.
Qi Zhao, Yiqiu Xu, +4 authors, Xuewen Huang.
Dis Markers, 2021 Aug 17; 2021. PMID: 34394775    Free PMC article.
Transarterial chemoembolization plus sorafenib versus sorafenib for intermediate-advanced hepatocellular carcinoma: A meta-analysis comparing clinical outcomes.
Yong Xie, Huan Tian, +4 authors, Hua Xiang.
Medicine (Baltimore), 2021 Aug 21; 100(33). PMID: 34414963    Free PMC article.
Systematic Review.
Emerging treatment modalities for systemic therapy in hepatocellular carcinoma.
Xin Qing, Wenjing Xu, +3 authors, Yewei Zhang.
Biomark Res, 2021 Aug 23; 9(1). PMID: 34419152    Free PMC article.
Microwave ablation compared with radiofrequency ablation for the treatment of liver cancer: a systematic review and meta-analysis.
Antonios E Spiliotis, Gereon Gäbelein, +3 authors, Bijendra Patel.
Radiol Oncol, 2021 Jun 25; 55(3). PMID: 34167181    Free PMC article.
Systematic Review.
Downstaging and resection of hepatocellular carcinoma in patients with extrahepatic metastases after stereotactic therapy.
Xiaobo Yang, Haifeng Xu, +13 authors, Haitao Zhao.
Hepatobiliary Surg Nutr, 2021 Aug 26; 10(4). PMID: 34430522    Free PMC article.
The Role of Immunotherapy in a Tolerogenic Environment: Current and Future Perspectives for Hepatocellular Carcinoma.
Liliana Montella, Federica Sarno, +9 authors, Gaetano Facchini.
Cells, 2021 Aug 28; 10(8). PMID: 34440678    Free PMC article.
Correlation of liver enhancement in gadoxetic acid-enhanced MRI with liver functions: a multicenter-multivendor analysis of hepatocellular carcinoma patients from SORAMIC trial.
Osman Öcal, Bora Peynircioglu, +16 authors, Max Seidensticker.
Eur Radiol, 2021 Sep 02; 32(2). PMID: 34467453    Free PMC article.
A Prospective Study of Liver Regeneration After Radiotherapy Based on a New (Su'S) Target Area Delineation.
Ting-Shi Su, Li-Qing Li, +4 authors, Le-Qun Li.
Front Oncol, 2021 Sep 14; 11. PMID: 34513671    Free PMC article.
Hepatobiliary phase signal intensity: A potential method of diagnosing HCC with atypical imaging features among LR-M observations.
Jae Hyon Park, Yong Eun Chung, +3 authors, Myeong-Jin Kim.
PLoS One, 2021 Sep 14; 16(9). PMID: 34516587    Free PMC article.
Increased Liquefactive Necrosis Formation After Transarterial Chemoembolization Combined with Molecular Targeted Agents Plus Immune Checkpoint Inhibitors for Hepatocellular Carcinoma.
Yingliang Wang, Chen Zhou, +6 authors, Bin Xiong.
Cancer Manag Res, 2021 Sep 16; 13. PMID: 34522136    Free PMC article.
Effects of surgery, chemotherapy, and radiation on hepatocellular carcinoma patients: A SEER-based study.
Kaif Qayum, Irfan Kar, +4 authors, Aliraza Syed.
Ann Med Surg (Lond), 2021 Sep 16; 69. PMID: 34522376    Free PMC article.
Therapeutic efficacy of a Dioscorea membranacea extract in a rat model of hepatocellular carcinoma: Histopathological aspects.
Vichununt Kerdput, Cheng Nilbu-Nga, +3 authors, Wisuit Pradidarcheep.
J Tradit Complement Med, 2021 Sep 16; 11(5). PMID: 34522634    Free PMC article.
Surveillance Strategy for Barcelona Clinic Liver Cancer B Hepatocellular Carcinoma Achieving Complete Response: An Individualized Risk-Based Machine Learning Study.
Qi-Feng Chen, Lin Dai, +3 authors, Ming Zhao.
Front Bioeng Biotechnol, 2021 Sep 21; 9. PMID: 34540812    Free PMC article.
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of hepatocellular carcinoma.
Tim F Greten, Ghassan K Abou-Alfa, +18 authors, Ignacio Melero.
J Immunother Cancer, 2021 Sep 15; 9(9). PMID: 34518290    Free PMC article.
Senescence in HBV-, HCV- and NAFLD- Mediated Hepatocellular Carcinoma and Senotherapeutics: Current Evidence and Future Perspective.
Vassilis G Giannakoulis, Peter Dubovan, +2 authors, John Koskinas.
Cancers (Basel), 2021 Sep 29; 13(18). PMID: 34572959    Free PMC article.
Long-Term Outcomes of Personalized Stereotactic Ablative Brachytherapy for Recurrent Head and Neck Adenoid Cystic Carcinoma after Surgery or External Beam Radiotherapy: A 9-Year Study.
Yi Chen, Jinzhao Dai, +5 authors, Junjie Wang.
J Pers Med, 2021 Sep 29; 11(9). PMID: 34575616    Free PMC article.
Therapeutic Ultrasound Parameter Optimization for Drug Delivery Applied to a Murine Model of Hepatocellular Carcinoma.
Arsenii V Telichko, Huaijun Wang, +4 authors, Jeremy J Dahl.
Ultrasound Med Biol, 2020 Nov 07; 47(2). PMID: 33153807    Free PMC article.
Immune aspects of hepatocellular carcinoma: From immune markers for early detection to immunotherapy.
Ângelo Z Mattos, Jose D Debes, +2 authors, Angelo A Mattos.
World J Gastrointest Oncol, 2021 Oct 08; 13(9). PMID: 34616518    Free PMC article.
Neoadjuvant Treatment with Angiogenesis-Inhibitor Dovitinib Prior to Local Therapy in Hepatocellular Carcinoma: A Phase II Study.
F J Sherida H Woei-A-Jin, Nir I Weijl, +6 authors, Susanne Osanto.
Oncologist, 2021 Jul 13; 26(10). PMID: 34251745    Free PMC article.
Association Between Adjuvant Sorafenib and the Prognosis of Patients With Hepatocellular Carcinoma at a High Risk of Recurrence After Radical Resection.
Qingli Li, Tianqiang Song.
Front Oncol, 2021 Oct 12; 11. PMID: 34631511    Free PMC article.
YRDC Mediates the Resistance of Lenvatinib in Hepatocarcinoma Cells via Modulating the Translation of KRAS.
Jun Guo, Peng Zhu, +7 authors, Qing Li.
Front Pharmacol, 2021 Oct 19; 12. PMID: 34658879    Free PMC article.
The Emerging Influences of Alpha-Fetoprotein in the Tumorigenesis and Progression of Hepatocellular Carcinoma.
Ye Xu, Qinglong Guo, Libin Wei.
Cancers (Basel), 2021 Oct 24; 13(20). PMID: 34680245    Free PMC article.
Association between Time to Local Tumor Control and Treatment Outcomes Following Repeated Loco-Regional Treatment Session in Patients with Hepatocellular Carcinoma: A Retrospective, Single-Center Study.
Krzysztof Bartnik, Wacław Hołówko, Olgierd Rowiński.
Life (Basel), 2021 Oct 24; 11(10). PMID: 34685433    Free PMC article.
Regorafenib combined with transarterial chemoembolization for unresectable hepatocellular carcinoma: a real-world study.
Yue Han, Guang Cao, +9 authors, Yinghua Zou.
BMC Gastroenterol, 2021 Oct 22; 21(1). PMID: 34670512    Free PMC article.
Non-invasive imaging criteria for the diagnosis of hepatocellular carcinoma in non-cirrhotic patients with chronic hepatitis B.
Carlos Moctezuma-Velázquez, Sara Lewis, +5 authors, Augusto Villanueva.
JHEP Rep, 2021 Oct 30; 3(6). PMID: 34712933    Free PMC article.
Baseline Liver Function and Subsequent Outcomes in the Phase 3 REFLECT Study of Patients with Unresectable Hepatocellular Carcinoma.
Arndt Vogel, Catherine Frenette, +10 authors, Masatoshi Kudo.
Liver Cancer, 2021 Nov 02; 10(5). PMID: 34721512    Free PMC article.
A New Prognostic Algorithm Predicting HCC Recurrence in Patients With Barcelona Clinic Liver Cancer Stage B Who Received PA-TACE.
Shuyang Hu, Wei Gan, +5 authors, Xiaoqing Jiang.
Front Oncol, 2021 Nov 09; 11. PMID: 34745962    Free PMC article.
Locoregional Treatments for Bridging and Downstaging HCC to Liver Transplantation.
Laura Crocetti, Elena Bozzi, +7 authors, Roberto Cioni.
Cancers (Basel), 2021 Nov 14; 13(21). PMID: 34771720    Free PMC article.
Prediction of Early Recurrence After Surgery for Liver Tumor (ERASL): An International Validation of the ERASL Risk Models.
Berend R Beumer, Kosei Takagi, +6 authors, Jan N M IJzermans.
Ann Surg Oncol, 2021 Jul 09; 28(13). PMID: 34235600    Free PMC article.
The Therapeutic Effect of Myrrh (Commiphora molmol) and Doxorubicin on Diethylnitrosamine Induced Hepatocarcinogenesis in Male Albino Rats.
Hend Mohamed Anwar, Asmaa M Moghazy, Amany Abd Elhameid Osman, Amina A S Abdel Rahman.
Asian Pac J Cancer Prev, 2021 Jul 29; 22(7). PMID: 34319038    Free PMC article.
Interventional Radiology Image-Guided Locoregional Therapies (LRTs) and Immunotherapy for the Treatment of HCC.
Pierpaolo Biondetti, Lorenzo Saggiante, +6 authors, Gianpaolo Carrafiello.
Cancers (Basel), 2021 Nov 28; 13(22). PMID: 34830949    Free PMC article.
The role of NK cells in oncolytic viral therapy: a focus on hepatocellular carcinoma.
Frazer Warricker, Salim I Khakoo, Matthew D Blunt.
J Transl Genet Genom, 2021 Dec 11; 5. PMID: 34888493    Free PMC article.
Revisiting Hepatic Artery Infusion Chemotherapy in the Treatment of Advanced Hepatocellular Carcinoma.
Ching-Tso Chen, Tsung-Hao Liu, +3 authors, Zhong-Zhe Lin.
Int J Mol Sci, 2021 Dec 11; 22(23). PMID: 34884684    Free PMC article.
A retrospective study of distribution of HIV associated malignancies among inpatients from 2007 to 2020 in China.
Fang Wang, Pan Xiang, +11 authors, Fujie Zhang.
Sci Rep, 2021 Dec 23; 11(1). PMID: 34934097    Free PMC article.
Is There Still a Place for Tyrosine Kinase Inhibitors for the Treatment of Hepatocellular Carcinoma at the Time of Immunotherapies? A Focus on Lenvatinib.
Marie Decraecker, Caroline Toulouse, Jean-Frédéric Blanc.
Cancers (Basel), 2021 Dec 25; 13(24). PMID: 34944930    Free PMC article.
Combination of Ablation and Immunotherapy for Hepatocellular Carcinoma: Where We Are and Where to Go.
Kunpeng Wang, Cong Wang, +4 authors, Chong Jin.
Front Immunol, 2022 Jan 04; 12. PMID: 34975896    Free PMC article.
Liver Transplantation in Hepatocellular Carcinoma: Experiences from the Shiraz Transplant Center.
A Dastyar, H Nikoupour, +9 authors, S Nikeghbalian.
Int J Organ Transplant Med, 2022 Jan 07; 12(2). PMID: 34987736    Free PMC article.
Clinical application of advances and innovation in radiation treatment of hepatocellular carcinoma.
Valerie J W Tong, Vishal G Shelat, Yew Kuo Chao.
J Clin Transl Res, 2022 Jan 07; 7(6). PMID: 34988334    Free PMC article.
Clinical Evaluation of Ramucirumab for the Treatment of Hepatocellular Carcinoma (HCC): Place in Therapy.
Khalil Choucair, Syed Kamran, Anwaar Saeed.
Onco Targets Ther, 2022 Jan 11; 14. PMID: 35002257    Free PMC article.
Hepatocellular Carcinoma With Portal Vein Tumor Thrombus Treated With Transarterial Chemoembolization and Sorafenib vs. 125Iodine Implantation.
Hong-Tao Hu, Jun-Peng Luo, +12 authors, Hai-Liang Li.
Front Oncol, 2022 Jan 11; 11. PMID: 35004330    Free PMC article.
LPCAT1 functions as a novel prognostic molecular marker in hepatocellular carcinoma.
Hongbin Zhang, Ke Xu, +15 authors, Tingxiu Xiang.
Genes Dis, 2020 Jul 21; 9(1). PMID: 35005115    Free PMC article.
Disease control and failure patterns of unresectable hepatocellular carcinoma following transarterial radioembolization with yttrium-90 microspheres and with/without sorafenib.
Ajalaya Teyateeti, Armeen Mahvash, +9 authors, Srinivas Cheenu Kappadath.
World J Gastroenterol, 2022 Jan 25; 27(47). PMID: 35068861    Free PMC article.
Combined treatments in hepatocellular carcinoma: Time to put them in the guidelines?
Zeno Sparchez, Pompilia Radu, +6 authors, Jean-François Dufour.
World J Gastrointest Oncol, 2022 Jan 25; 13(12). PMID: 35070032    Free PMC article.
Prediction of late recurrence after radiofrequency ablation of HBV-related hepatocellular carcinoma with the age-male-albumin-bilirubin-platelets (aMAP) risk score: a multicenter study.
Yujing Xin, Xinyuan Zhang, +4 authors, Xiao Li.
J Gastrointest Oncol, 2022 Jan 25; 12(6). PMID: 35070419    Free PMC article.
Differential Diagnosis of Hepatic Mass with Central Scar: Focal Nodular Hyperplasia Mimicking Fibrolamellar Hepatocellular Carcinoma.
Teodoro Rudolphi-Solero, Eva María Triviño-Ibáñez, +6 authors, Antonio Rodríguez-Fernández.
Diagnostics (Basel), 2022 Jan 22; 12(1). PMID: 35054211    Free PMC article.
Comparison of clinical outcome between stereotactic body radiotherapy and radiofrequency ablation for unresectable hepatocellular carcinoma.
Ren Ji, Kelvin K Ng, +8 authors, Chung-Mau Lo.
Medicine (Baltimore), 2022 Jan 29; 101(4). PMID: 35089192    Free PMC article.
Safety and Efficacy of Transarterial Chemoembolization Combined With Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma.
Fei Yang, Jun Yang, +8 authors, Xiao-Li Zhu.
Front Oncol, 2022 Feb 01; 11. PMID: 35096555    Free PMC article.
Impact of Platelet Count on Perioperative Bleeding in Patients With Cirrhosis Undergoing Surgical Treatments of Liver Cancer.
Vincenzo Ronca, Matteo Barabino, +8 authors, Gian Marco Podda.
Hepatol Commun, 2021 Oct 31; 6(2). PMID: 34716696    Free PMC article.
Prognostic effect of systemic inflammation in patients undergoing surgery for hepatocellular carcinoma: comparison of composite ratios and cumulative scores.
Xin Wu, Zhirong Sun, Yun Zhu.
Transl Cancer Res, 2020 Oct 01; 9(10). PMID: 35117226    Free PMC article.
Post-treatment three-dimensional voxel-based dosimetry after Yttrium-90 resin microsphere radioembolization in HCC.
Emile B Veenstra, Simeon J S Ruiter, +3 authors, Walter Noordzij.
EJNMMI Res, 2022 Feb 06; 12(1). PMID: 35122166    Free PMC article.
Understanding the patient experience in hepatocellular carcinoma: a qualitative patient interview study.
Nikunj Patel, Joshua Maher, +11 authors, Gordon Cohen.
Qual Life Res, 2021 Jun 12; 31(2). PMID: 34115280    Free PMC article.
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update.
Maria Reig, Alejandro Forner, +13 authors, Jordi Bruix.
J Hepatol, 2021 Nov 22; 76(3). PMID: 34801630    Free PMC article.
Precision Medicine for Hepatocellular Carcinoma: Clinical Perspective.
Danijel Galun, Dragana Mijac, +3 authors, Dragan Masulovic.
J Pers Med, 2022 Feb 26; 12(2). PMID: 35207638    Free PMC article.
Multiple Light-Activated Photodynamic Therapy of Tetraphenylethylene Derivative with AIE Characteristics for Hepatocellular Carcinoma via Dual-Organelles Targeting.
Chuxing Chai, Tao Zhou, +7 authors, Chidan Wan.
Pharmaceutics, 2022 Feb 27; 14(2). PMID: 35214196    Free PMC article.
Advances in Nanoliposomes for the Diagnosis and Treatment of Liver Cancer.
Yitong Li, Ruihang Zhang, Zhen Xu, Zhicheng Wang.
Int J Nanomedicine, 2022 Mar 08; 17. PMID: 35250267    Free PMC article.
Mutational signatures and processes in hepatobiliary cancers.
Ekaterina Zhuravleva, Colm J O'Rourke, Jesper B Andersen.
Nat Rev Gastroenterol Hepatol, 2022 Mar 12; 19(6). PMID: 35273358
68Ga-PSMA-11 PET/CT Improves Tumor Detection and Impacts Management in Patients with Hepatocellular Carcinoma.
Nader Hirmas, Catherine Leyh, +12 authors, Wolfgang P Fendler.
J Nucl Med, 2021 Jan 30; 62(9). PMID: 33509970    Free PMC article.
A national dose analysis of guided tumor destruction: influence of sex, age, localization and destruction technique used.
Matthieu Rojo, Aymeric Hamard, +4 authors, Julien Frandon.
Quant Imaging Med Surg, 2022 Mar 15; 12(3). PMID: 35284251    Free PMC article.
Hepatocellular carcinoma with complete response to the immunotherapy: the oncologist's dilemma.
Mansour Al-Moundhri, Antonio Cubisino, Fabrizio Panaro.
Hepatobiliary Surg Nutr, 2022 Mar 15; 11(1). PMID: 35284505    Free PMC article.
Lenvatinib Plus Camrelizumab vs. Lenvatinib Monotherapy as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Cohort Study.
Qi Li, Mengran Cao, +9 authors, Jinzhang Chen.
Front Oncol, 2022 Mar 15; 12. PMID: 35280760    Free PMC article.
Scoring systems for the management of oncological hepato-pancreato-biliary patients.
Alexander W Coombs, Chloe Jordan, Sabba A Hussain, Omar Ghandour.
Ann Hepatobiliary Pancreat Surg, 2022 Feb 28; 26(1). PMID: 35220286    Free PMC article.
Transarterial Chemoembolization Combined With Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors for Unresectable Hepatocellular Carcinoma: Efficacy and Systemic Immune Response.
Fei Yang, Gui-Li Xu, +10 authors, Xiao-Li Zhu.
Front Immunol, 2022 Mar 19; 13. PMID: 35300339    Free PMC article.
Real-world efficiency of lenvatinib plus PD-1 blockades in advanced hepatocellular carcinoma: an exploration for expanded indications.
Xuqi Sun, Qi Zhang, +3 authors, Tingbo Liang.
BMC Cancer, 2022 Mar 21; 22(1). PMID: 35305593    Free PMC article.
A Novel Multimodal Radiomics Model for Predicting Prognosis of Resected Hepatocellular Carcinoma.
Ying He, Bin Hu, +7 authors, Xianjun Zhou.
Front Oncol, 2022 Mar 25; 12. PMID: 35321432    Free PMC article.
The Role of LSD1 and LSD2 in Cancers of the Gastrointestinal System: An Update.
Gianluca Malagraba, Mahdieh Yarmohammadi, +2 authors, Teresa Rubio-Tomás.
Biomolecules, 2022 Mar 26; 12(3). PMID: 35327654    Free PMC article.
Multimarker Panels for Detection of Early Stage Hepatocellular Carcinoma: A Prospective, Multicenter, Case-Control Study.
Teerha Piratvisuth, Tawesak Tanwandee, +8 authors, Henry Lik-Yuen Chan.
Hepatol Commun, 2021 Nov 20; 6(4). PMID: 34796691    Free PMC article.
Cost-Effectiveness Analysis of Follow-Up Schedule for Hepatocellular Carcinoma after Radiofrequency Ablation.
Shuifang Hu, Xiaoxue Wu, +6 authors, Zhenwei Peng.
J Oncol, 2022 Mar 30; 2022. PMID: 35345515    Free PMC article.
Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Camrelizumab Compared With Conventional Transarterial Chemoembolization Plus Camrelizumab for Unresectable Hepatocellular Carcinoma.
Yanqiao Ren, Yusheng Guo, +6 authors, Chuansheng Zheng.
Cancer Control, 2022 Mar 29; 29. PMID: 35343254    Free PMC article.
Randomized Phase 3 LEAP-012 Study: Transarterial Chemoembolization With or Without Lenvatinib Plus Pembrolizumab for Intermediate-Stage Hepatocellular Carcinoma Not Amenable to Curative Treatment.
Josep M Llovet, Arndt Vogel, +8 authors, Masatoshi Kudo.
Cardiovasc Intervent Radiol, 2022 Feb 05; 45(4). PMID: 35119481    Free PMC article.
Effects of Stereotactic Body Radiation Therapy Plus PD-1 Inhibitors for Patients With Transarterial Chemoembolization Refractory.
Yan-Jun Xiang, Kang Wang, +11 authors, Shu-Qun Cheng.
Front Oncol, 2022 Apr 08; 12. PMID: 35387113    Free PMC article.
Systemic Therapy for Hepatocellular Carcinoma: Current Updates and Outlook.
Yinjie Fan, Hang Xue, Huachuan Zheng.
J Hepatocell Carcinoma, 2022 Apr 08; 9. PMID: 35388357    Free PMC article.
Tenofovir vs. Entecavir on Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma after Radiofrequency Ablation.
Zili Hu, Huilan Zeng, +5 authors, Zhongguo Zhou.
Viruses, 2022 Apr 24; 14(4). PMID: 35458386    Free PMC article.
Molecular pathogenesis and systemic therapies for hepatocellular carcinoma.
Josep M Llovet, Roser Pinyol, +5 authors, Augusto Villanueva.
Nat Cancer, 2022 Apr 29; 3(4). PMID: 35484418    Free PMC article.
Indirect Comparisons via Sorafenib for the Comparative Effectiveness of Two PD-1/PD-L1 Inhibitors to Treat Advanced Hepatocellular Carcinoma Patients without Prior Systemic Therapies.
Yawen Jiang, Dan Cai, Si Shi.
Clin Epidemiol, 2022 May 07; 14. PMID: 35520275    Free PMC article.
Chimeric HDAC and the cytoskeleton inhibitor broxbam as a novel therapeutic strategy for liver cancer.
Sofia Isolde Bär, Alexandra Dittmer, +7 authors, Michael Höpfner.
Int J Oncol, 2022 Apr 30; 60(6). PMID: 35485292    Free PMC article.
Muscarinic Receptors Associated with Cancer.
Gloria M Calaf, Leodan A Crispin, +2 authors, Tammy C Bleak.
Cancers (Basel), 2022 May 15; 14(9). PMID: 35565451    Free PMC article.
Identification and Validation of Novel Biomarkers for Hepatocellular Carcinoma, Liver Fibrosis/Cirrhosis and Chronic Hepatitis B via Transcriptome Sequencing Technology.
Dandan Zhao, Xiaoxiao Zhang, +16 authors, Yuemin Nan.
J Hepatocell Carcinoma, 2022 May 21; 9. PMID: 35592243    Free PMC article.
Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma.
Philip Johnson, Qing Zhou, Doan Y Dao, Y M Dennis Lo.
Nat Rev Gastroenterol Hepatol, 2022 Jun 09;. PMID: 35676420